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Coronary Artery Disease
Ma#hew Jarboe BSN
O#erbein University, Westerville, Ohio

Introduc7on
Coronary artery disease (CAD) is a
highly prevalent disease in the United
States populous. U.S. healthcare cost
related to CAD was over
$126,000,000,000 annually in 2010. The
cost is expected to rise 41% by 2040
(Odden, et al., 2011, p 829). CAD is a
major burden for the U.S. health care
system projected to worsen with the
aging of the popula7on.
Coronary artery disease directly
impacts my current prac7ce in the
Cardio-Vascular Intensive Care Unit
(CVICU). Working in the CVICU, a large
percentage of the pa7ent popula7on has
undergone Coronary Artery Bypass
Graling (CABG). CABG surgery is
performed on pa7ents who have
developed CAD. Furthering my
pathological knowledge of this disease
state will improve the quality of
educa7on I can deliver to my pa7ents.
This project should also improve the
level of care I deliver by deepening my
insight into this disease.
Addi7onally, I have a strong family
history of CAD, so it is of personal
interest.

Signs and Symptoms
Coronary artery disease is a silent
disease process un7l it progresses to a
symptoma7c stage. According to the
Na7onal Heart, Lung and Blood
Ins7tute (2016), some people with CAD
show no signs or symptoms un7l they
are having a heart adack, arrhythmia,
or heart failure. Other people develop
signs and symptoms before they
develop these related condi7ons. CAD
causes myocardial ischemia, which can
present as stable angina or prinzmetal
angina.
Signs and symptoms of myocardial
ischemia may include lel sternal chest
pain, chest 7ghtness or pressure,
shortness of breath, diaphoresis, and
pallor (McCance & Huether, 2014,
p1154). Aler coronary artery disease
has progressed; heart failure,
arrhythmia, and myocardial infarc7on
(heart adack) can cause more severe
signs and symptoms.
Myocardial infarc7on (MI) is a
serious consequence of advanced CAD.
The signs and symptoms of a heart
adack include sudden crushing chest
pain, described as “an elephant siong
on my chest” (McCance & Huether,
2014, p1160).

Nausea and vomi7ng can be caused
from the pain nerve ﬁbers s7mula7ng
the vomi7ng centers. Pain radiates to
the back, jaw, neck, lel arm, and
shoulder. A feeling of relentless
indiges7on has also been described
(McCance & Huether, 2014, p1160).
The Na7onal Heart, Lung and Blood
Ins7tute (2016) list these signs and
symptoms of a heart adack: nausea,
vomi7ng, light-headedness, sleep
problems, fain7ng, cold sweats, lack of
energy, fa7gue, and bilateral arm pain.
Many of the signs and symptoms of
heart failure are associated with the
hearts inability to pump adequately
and the associated ﬂuid build up. The
Na7onal Heart, Lung and Blood
Ins7tute (2016) states that heart
failure leads to 7redness, shortness of
breath, fa7gue, trouble breathing,
swelling in the feet, legs, and stomach,
and neck vein disten7on.
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Pathophysiology
Coronary artery disease is the result of
atherosclerosis in the arterial vessels of the
heart. Atherosclerosis is also responsible
for renal artery stenosis, caro7d artery
stenosis, and lower extremity peripheral
artery disease (Imori et al., 2014).
Atherosclerosis narrows the lumen of
arterial vessels, leading to a decreased
supply of oxygen and nutri7on to the
myocardium. This depriva7on in blood ﬂow
and the resul7ng lack of oxygen and
nutrients, leads to myocardial ischemia. If
ischemia is prolonged or the blood vessel
becomes totally occluded it can lead to
acute coronary syndrome (McCance &
Huether, 2014, p. 1148).
The pathophysiological process of
atherosclerosis is important in the
development CAD. Listed are the
pathophysiological steps leading to
atherosclerosis as discussed by McCance
and Huether (2014) on pages 1145-1147:
1. Low-density lipoprotein (LDL)
accumulates within arterial vessel
walls.
2. Injury occurs to the endothelium of the
arterial vessel wall. Hypertension,
diabetes mellitus, smoking,
autoimmune response, and
dyslipidemia contribute to this injury.
3. Once damaged, the endothelial cells
stop producing adequate amounts of
vasodilator and an7thrombo7c
cytokines.
4. Pro-inﬂammatory cytokine are released
by damaged endothelial cell allowing
macrophage and leukocyte adherence
to the endothelium.
5. Macrophage release toxic oxygen
radicals and enzymes that result in
oxida7ve stress, causing LDL to oxidize,
further injuring the vessel wall.
6. Oxidized LDL undergo phagocytosis by
macrophages crea7ng foam cells.
7. Foam cells accumulate in the
endothelium crea7ng fady streaks. A
collagen layer forms over top of the
fady streaks crea7ng a ﬁbrous plaque.
8. Fibrous plaques can decrease blood
ﬂow causing signs and symptoms
ischemia.

The development of ﬁbrous plaque is
the founda7on of atherosclerosis. The
majority of ﬁbrous plaques have the
poten7al to rupture. Pro7enases causes
apoptosis within the ﬁbrous plague, which
leads to bleeding from the plaque. The
cloong cascade is ac7vated and a rapid
thrombus forms occluding the vessel.
Plaque rupture is known as a complicated
plaque. “Other causes of thrombosis
include plaque erosion which is less
frequent than plaque rupture but is a
common cause of thrombosis in young
individuals especially women <50 years of
age” (Sakakura et al., 2013).
Occlusion of the lumen is responsible
for many of the signs and symptoms
caused by CAD. Calciﬁed plaques are the
least likely to rupture and occlude the
lumen.
Autoimmune ideologies for decreased
lumen size cannot be ruled out. A study
by Patel, Anzalone, Buja, and Elghetany
(2014) found that Immunoglobulin G4–
related disease can result in ﬁbro7c
overgrowth in the endothelium causing
severe lumen obstruc7on.
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Signiﬁcance of Pathophysiology
Preven7on of atherosclerosis should
be the primary goal in treatment of CAD.
One of the most widely used medica7ons
in the preven7on and treatment of CAD
are HMG-CoA reductase inhibitors.
“HMG-CoA reductase inhibitors, also
known as sta7ns, selec7vely inhibit an
enzyme called HMG-CoA reductase (3hydroxy-3-methylglutaryl coenzyme A
reductase) that is involved in the
synthesis of mevalonate, a precursor
of sterols including cholesterol. By
inhibi7ng this enzyme, cholesterol and
LDL-cholesterol produc7on is
decreased. Sta7ns also increase the
number of LDL receptors on liver cells,
which enhances the uptake and
breakdown of LDL-cholesterol. Most
of the eﬀects of sta7ns occur in the
liver. Research has shown that
elevated levels of total cholesterol,
LDL-cholesterol, and apolipoprotein B
are risk factors for developing
cardiovascular disease.” (Anderson,
Stewart, Thornton, Wilson, Fookes, &
Puckey, (Eds.). 2017).
Apolipoprotein B (apoB) levels are the
best predictor of fatal myocardial
infarc7on. ApoB is a beder predictor than
LDL at screening for future ischemic
cardiovascular events, but LDL is the
current standard in the U.S. (Benn,
Nordestgaard, Jensen, & TybjaergHansen, 2007, p. 661). Decreasing the
circula7ng LDL level forces the body to
pull the LDL out of ﬁbrous plaques in the
arterial walls. Plaque passiva7on is the
process by which sta7ns stabilize ac7ve
plaques at risk for rupture (Pradka, 2000,
p. 43).
According to Bibbins-Domingo (2016)
“USPSTF recommends ini7a7ng use of
low- to moderate-dose sta7ns in adults
aged 40 to 75 years without a history of
CVD who have 1 or more CVD risk factors
(dyslipidemia, diabetes, hypertension, or
smoking) and a calculated 10-year CVD
event risk of 10% or greater (B
recommenda7on).” While the beneﬁts of
sta7ns in the preven7on of CAD has been
well documented; research conducted by
Rothschild, Novak, and Rich (2016) found
that sta7n therapy did not signiﬁcantly
improve mortality in individuals over the
age of 80 who were hospitalized with
myocardial infarc7on.

Treatment of the other underlying
causes of CAD is important as well.
Controlling hypertension and diabetes
mellitus are crucial components in
preven7ng CAD. Tobacco cessa7on
should also be recommended.
Surprisingly, a study by Reis et al.
(2017) found that Marijuana use is not
associated with an increase risk of CAD.
Understanding the root causes of CAD
will lead to beder treatment
recommenda7ons from providers.
Unfortunately, gene7c tes7ng has not
been found to be economically viable in
detec7ng CAD (Hochheiser, Juusola,
Monane, & Ladapo, 2014). Developing
beder tes7ng and treatment op7ons
could mi7gate the future cost of this
highly prevalent disease.

Implica7ons for
Nursing Care
Listed are the steps needed to reduce the
risk of cardiac events (Pradka, 2000, p.
43):
1. smoking cessa7on
2. hypertension control
3. regular physical ac7vity
4. aggressive lowering of elevated lowdensity lipoprotein (LDL) values
5. losing weight
6. making healthier dietary choices
A study by Dmitrieva, and Burg (2015),
found that elevated serum sodium levels,
even within the normal range, is
associated with vascular changes that
facilitate CAD. The U.S. Food and Drug
Administra7on (2016) recommends
2300mg of sodium per day for U.S. adults
and 1500mg per day for hypertensive and
pre-hypertensive individuals.
Medica7on educa7on is another
important area of nursing care. Pa7ents
need to understand why they are taking
their medica7ons, and the importance
these medica7ons have in trea7ng their
condi7on. When pa7ents do not
understand why they are taking
medica7ons, they are more likely to stop
taking them without consul7ng their
provider.

Conclusion
Coronary artery disease aﬀects
millions of Americans. The consequences
of untreated CAD can be detrimental to
ones quality of life. There are modiﬁable
risk factors such as dyslipidemia,
hypertension, and diabetes mellitus that
should be controlled when possible.
Lifestyle changes can also have a
signiﬁcant impact on the course of CAD.
As healthcare providers, we should do our
best to minimize the impact that coronary
artery disease has on our pa7ent
popula7on.
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